Black Rock Inc. Tiziana Life Sciences LTD Transaction History

Black Rock Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.06 $19,115 - $30,700	-28,963 Reduced 94.59%	1,656 $1,000
Q4 2021 Feb 10, 2022	BUY	$0.89 - $1.66 $27,250 - $50,827	30,619 New	30,619 $29,000

1.03M

19.2K

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $91M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.